Vimarsana
Biggest News Aggregation in the World

Jubilant Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jubilant Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jubilant Life Sciences Today - Breaking & Trending Today

Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030 - Vimarsana News

Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030

/PRNewswire/ -- DelveInsight's Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation...

DelveInsight Business Research, LLP: Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030 - Vimarsana News

DelveInsight Business Research, LLP: Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of ~9% by 2030

The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of

Small Molecule CMO/CDMO Market Outlook 2024-2033: Rising - Vimarsana News

Small Molecule CMO/CDMO Market Outlook 2024-2033: Rising

Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The

Small Molecule Innovator Cdmo Market Poised For Substantial Growth, Forecasted To Surpass USD 84.7 B - Vimarsana News

Small Molecule Innovator Cdmo Market Poised For Substantial Growth, Forecasted To Surpass USD 84.7 B

Marketresearch.biz reports that the global small molecule innovator CDMO market revenue is expected to increase to USD 84.7 Bn in 2032 from USD 45.4 Bn in 2022, and register a revenue CAGR of 6.6% during the forecast period (2023 to 2032).Overview of the Small Molecule Innovator CDMO MarketThe Small Molecule Innovat...

Jubilant unit makes over five-fold gain by selling stake in US firm - Vimarsana News

Jubilant unit makes over five-fold gain by selling stake in US firm

Jubilant Pharma Ltd, a Singapore-based subsidiary of Mumbai-listed Jubilant Pharmova Ltd, will sell its entire stake in a US company as part of a larger ......